Medical Care
Global NGS-based RNA-sequencing Market Research Report 2025
- Sep 18, 25
- ID: 507611
- Pages: 82
- Figures: 83
- Views: 9
This report aims to provide a comprehensive presentation of the global market for NGS-based RNA-sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-based RNA-sequencing.
The NGS-based RNA-sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NGS-based RNA-sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGS-based RNA-sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Segment by Application
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-based RNA-sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The NGS-based RNA-sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NGS-based RNA-sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGS-based RNA-sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Segment by Application
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-based RNA-sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2020-2031)
2.2 Global NGS-based RNA-sequencing Growth Trends by Region
2.2.1 Global NGS-based RNA-sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2020-2025)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2026-2031)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-sequencing Players by Revenue
3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2020-2025)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2020-2025)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2024
3.5 Global Key Players of NGS-based RNA-sequencing Head office and Area Served
3.6 Global Key Players of NGS-based RNA-sequencing, Product and Application
3.7 Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2020-2025)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2026-2031)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2020-2025)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2020-2031)
6.2 North America NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NGS-based RNA-sequencing Market Size by Country (2020-2025)
6.4 North America NGS-based RNA-sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2020-2031)
7.2 Europe NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NGS-based RNA-sequencing Market Size by Country (2020-2025)
7.4 Europe NGS-based RNA-sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2020-2031)
8.2 Asia-Pacific NGS-based RNA-sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size (2020-2031)
9.2 Latin America NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2020-2025)
9.4 Latin America NGS-based RNA-sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2020-2031)
10.2 Middle East & Africa NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Details
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.3.5 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.5.5 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.6.5 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.8.5 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.9.5 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Details
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Details
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Details
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Details
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.15.5 Tecan Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2020-2031)
2.2 Global NGS-based RNA-sequencing Growth Trends by Region
2.2.1 Global NGS-based RNA-sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2020-2025)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2026-2031)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-sequencing Players by Revenue
3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2020-2025)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2020-2025)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2024
3.5 Global Key Players of NGS-based RNA-sequencing Head office and Area Served
3.6 Global Key Players of NGS-based RNA-sequencing, Product and Application
3.7 Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2020-2025)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2026-2031)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2020-2025)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2020-2031)
6.2 North America NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NGS-based RNA-sequencing Market Size by Country (2020-2025)
6.4 North America NGS-based RNA-sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2020-2031)
7.2 Europe NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NGS-based RNA-sequencing Market Size by Country (2020-2025)
7.4 Europe NGS-based RNA-sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2020-2031)
8.2 Asia-Pacific NGS-based RNA-sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size (2020-2031)
9.2 Latin America NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2020-2025)
9.4 Latin America NGS-based RNA-sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2020-2031)
10.2 Middle East & Africa NGS-based RNA-sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Details
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.3.5 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.5.5 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.6.5 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.8.5 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.9.5 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Details
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Details
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Details
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Details
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2020-2025)
11.15.5 Tecan Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sequencing by Synthesis
Table 3. Key Players of Ion Semiconductor Sequencing
Table 4. Key Players of Single-molecule Real-time Sequencing
Table 5. Key Players of Nanopore Sequencing
Table 6. Global NGS-based RNA-sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global NGS-based RNA-sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global NGS-based RNA-sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global NGS-based RNA-sequencing Market Share by Region (2020-2025)
Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global NGS-based RNA-sequencing Market Share by Region (2026-2031)
Table 12. NGS-based RNA-sequencing Market Trends
Table 13. NGS-based RNA-sequencing Market Drivers
Table 14. NGS-based RNA-sequencing Market Challenges
Table 15. NGS-based RNA-sequencing Market Restraints
Table 16. Global NGS-based RNA-sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global NGS-based RNA-sequencing Market Share by Players (2020-2025)
Table 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2024)
Table 19. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of NGS-based RNA-sequencing, Headquarters and Area Served
Table 22. Global Key Players of NGS-based RNA-sequencing, Product and Application
Table 23. Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NGS-based RNA-sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2020-2025)
Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2026-2031)
Table 29. Global NGS-based RNA-sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global NGS-based RNA-sequencing Revenue Market Share by Application (2020-2025)
Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global NGS-based RNA-sequencing Revenue Market Share by Application (2026-2031)
Table 33. North America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific NGS-based RNA-sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Illumina Company Details
Table 49. Illumina Business Overview
Table 50. Illumina NGS-based RNA-sequencing Product
Table 51. Illumina Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 52. Illumina Recent Development
Table 53. Thermo Fischer Scientific Company Details
Table 54. Thermo Fischer Scientific Business Overview
Table 55. Thermo Fischer Scientific NGS-based RNA-sequencing Product
Table 56. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 57. Thermo Fischer Scientific Recent Development
Table 58. Oxford Nanopore Company Details
Table 59. Oxford Nanopore Business Overview
Table 60. Oxford Nanopore NGS-based RNA-sequencing Product
Table 61. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 62. Oxford Nanopore Recent Development
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies NGS-based RNA-sequencing Product
Table 66. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. BGI Company Details
Table 69. BGI Business Overview
Table 70. BGI NGS-based RNA-sequencing Product
Table 71. BGI Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 72. BGI Recent Development
Table 73. PerkinElmer Company Details
Table 74. PerkinElmer Business Overview
Table 75. PerkinElmer NGS-based RNA-sequencing Product
Table 76. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 77. PerkinElmer Recent Development
Table 78. QIAGEN Company Details
Table 79. QIAGEN Business Overview
Table 80. QIAGEN NGS-based RNA-sequencing Product
Table 81. QIAGEN Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 82. QIAGEN Recent Development
Table 83. Eurofins Scientific Company Details
Table 84. Eurofins Scientific Business Overview
Table 85. Eurofins Scientific NGS-based RNA-sequencing Product
Table 86. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 87. Eurofins Scientific Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche NGS-based RNA-sequencing Product
Table 91. Roche Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Takara Bio Company Details
Table 94. Takara Bio Business Overview
Table 95. Takara Bio NGS-based RNA-sequencing Product
Table 96. Takara Bio Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 97. Takara Bio Recent Development
Table 98. GENEWIZ Company Details
Table 99. GENEWIZ Business Overview
Table 100. GENEWIZ NGS-based RNA-sequencing Product
Table 101. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 102. GENEWIZ Recent Development
Table 103. Hamilton Company Details
Table 104. Hamilton Business Overview
Table 105. Hamilton NGS-based RNA-sequencing Product
Table 106. Hamilton Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 107. Hamilton Recent Development
Table 108. Macrogen Company Details
Table 109. Macrogen Business Overview
Table 110. Macrogen NGS-based RNA-sequencing Product
Table 111. Macrogen Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 112. Macrogen Recent Development
Table 113. Zymo Research Company Details
Table 114. Zymo Research Business Overview
Table 115. Zymo Research NGS-based RNA-sequencing Product
Table 116. Zymo Research Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 117. Zymo Research Recent Development
Table 118. Tecan Genomics Company Details
Table 119. Tecan Genomics Business Overview
Table 120. Tecan Genomics NGS-based RNA-sequencing Product
Table 121. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 122. Tecan Genomics Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. NGS-based RNA-sequencing Picture
Figure 2. Global NGS-based RNA-sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NGS-based RNA-sequencing Market Share by Type: 2024 VS 2031
Figure 4. Sequencing by Synthesis Features
Figure 5. Ion Semiconductor Sequencing Features
Figure 6. Single-molecule Real-time Sequencing Features
Figure 7. Nanopore Sequencing Features
Figure 8. Global NGS-based RNA-sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global NGS-based RNA-sequencing Market Share by Application: 2024 VS 2031
Figure 10. Research & Academia Case Studies
Figure 11. Hospitals & Clinics Case Studies
Figure 12. Pharmaceutical & Biotechnology Companies Case Studies
Figure 13. Others Case Studies
Figure 14. NGS-based RNA-sequencing Report Years Considered
Figure 15. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global NGS-based RNA-sequencing Market Share by Region: 2024 VS 2031
Figure 18. Global NGS-based RNA-sequencing Market Share by Players in 2024
Figure 19. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2024
Figure 21. North America NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 23. United States NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 27. Germany NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2020-2031)
Figure 35. China NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 43. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 47. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 51. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 52. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 53. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 54. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 55. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 56. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 57. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 58. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 59. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 60. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 61. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 62. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 63. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 64. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sequencing by Synthesis
Table 3. Key Players of Ion Semiconductor Sequencing
Table 4. Key Players of Single-molecule Real-time Sequencing
Table 5. Key Players of Nanopore Sequencing
Table 6. Global NGS-based RNA-sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global NGS-based RNA-sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global NGS-based RNA-sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global NGS-based RNA-sequencing Market Share by Region (2020-2025)
Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global NGS-based RNA-sequencing Market Share by Region (2026-2031)
Table 12. NGS-based RNA-sequencing Market Trends
Table 13. NGS-based RNA-sequencing Market Drivers
Table 14. NGS-based RNA-sequencing Market Challenges
Table 15. NGS-based RNA-sequencing Market Restraints
Table 16. Global NGS-based RNA-sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global NGS-based RNA-sequencing Market Share by Players (2020-2025)
Table 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2024)
Table 19. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of NGS-based RNA-sequencing, Headquarters and Area Served
Table 22. Global Key Players of NGS-based RNA-sequencing, Product and Application
Table 23. Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NGS-based RNA-sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2020-2025)
Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2026-2031)
Table 29. Global NGS-based RNA-sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global NGS-based RNA-sequencing Revenue Market Share by Application (2020-2025)
Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global NGS-based RNA-sequencing Revenue Market Share by Application (2026-2031)
Table 33. North America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific NGS-based RNA-sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Illumina Company Details
Table 49. Illumina Business Overview
Table 50. Illumina NGS-based RNA-sequencing Product
Table 51. Illumina Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 52. Illumina Recent Development
Table 53. Thermo Fischer Scientific Company Details
Table 54. Thermo Fischer Scientific Business Overview
Table 55. Thermo Fischer Scientific NGS-based RNA-sequencing Product
Table 56. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 57. Thermo Fischer Scientific Recent Development
Table 58. Oxford Nanopore Company Details
Table 59. Oxford Nanopore Business Overview
Table 60. Oxford Nanopore NGS-based RNA-sequencing Product
Table 61. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 62. Oxford Nanopore Recent Development
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies NGS-based RNA-sequencing Product
Table 66. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. BGI Company Details
Table 69. BGI Business Overview
Table 70. BGI NGS-based RNA-sequencing Product
Table 71. BGI Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 72. BGI Recent Development
Table 73. PerkinElmer Company Details
Table 74. PerkinElmer Business Overview
Table 75. PerkinElmer NGS-based RNA-sequencing Product
Table 76. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 77. PerkinElmer Recent Development
Table 78. QIAGEN Company Details
Table 79. QIAGEN Business Overview
Table 80. QIAGEN NGS-based RNA-sequencing Product
Table 81. QIAGEN Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 82. QIAGEN Recent Development
Table 83. Eurofins Scientific Company Details
Table 84. Eurofins Scientific Business Overview
Table 85. Eurofins Scientific NGS-based RNA-sequencing Product
Table 86. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 87. Eurofins Scientific Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche NGS-based RNA-sequencing Product
Table 91. Roche Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Takara Bio Company Details
Table 94. Takara Bio Business Overview
Table 95. Takara Bio NGS-based RNA-sequencing Product
Table 96. Takara Bio Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 97. Takara Bio Recent Development
Table 98. GENEWIZ Company Details
Table 99. GENEWIZ Business Overview
Table 100. GENEWIZ NGS-based RNA-sequencing Product
Table 101. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 102. GENEWIZ Recent Development
Table 103. Hamilton Company Details
Table 104. Hamilton Business Overview
Table 105. Hamilton NGS-based RNA-sequencing Product
Table 106. Hamilton Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 107. Hamilton Recent Development
Table 108. Macrogen Company Details
Table 109. Macrogen Business Overview
Table 110. Macrogen NGS-based RNA-sequencing Product
Table 111. Macrogen Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 112. Macrogen Recent Development
Table 113. Zymo Research Company Details
Table 114. Zymo Research Business Overview
Table 115. Zymo Research NGS-based RNA-sequencing Product
Table 116. Zymo Research Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 117. Zymo Research Recent Development
Table 118. Tecan Genomics Company Details
Table 119. Tecan Genomics Business Overview
Table 120. Tecan Genomics NGS-based RNA-sequencing Product
Table 121. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2020-2025) & (US$ Million)
Table 122. Tecan Genomics Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. NGS-based RNA-sequencing Picture
Figure 2. Global NGS-based RNA-sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NGS-based RNA-sequencing Market Share by Type: 2024 VS 2031
Figure 4. Sequencing by Synthesis Features
Figure 5. Ion Semiconductor Sequencing Features
Figure 6. Single-molecule Real-time Sequencing Features
Figure 7. Nanopore Sequencing Features
Figure 8. Global NGS-based RNA-sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global NGS-based RNA-sequencing Market Share by Application: 2024 VS 2031
Figure 10. Research & Academia Case Studies
Figure 11. Hospitals & Clinics Case Studies
Figure 12. Pharmaceutical & Biotechnology Companies Case Studies
Figure 13. Others Case Studies
Figure 14. NGS-based RNA-sequencing Report Years Considered
Figure 15. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global NGS-based RNA-sequencing Market Share by Region: 2024 VS 2031
Figure 18. Global NGS-based RNA-sequencing Market Share by Players in 2024
Figure 19. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2024
Figure 21. North America NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 23. United States NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 27. Germany NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2020-2031)
Figure 35. China NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 43. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa NGS-based RNA-sequencing Market Share by Country (2020-2031)
Figure 47. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE NGS-based RNA-sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 51. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 52. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 53. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 54. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 55. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 56. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 57. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 58. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 59. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 60. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 61. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 62. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 63. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 64. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232